The pathogenesis of dilated cardiomyopathy

Area of Science:

• Cardiology
• Pathology
• Virology

Background:

• Dilated cardiomyopathy's etiology remains largely unknown, prompting research into pathogenetic mechanisms.
• Endomyocardial biopsies have revealed myocarditis as a key factor in dilated cardiomyopathy development.
• Myocarditis diagnosis historically presented challenges, necessitating standardized criteria.

Purpose of the Study:

• To define diagnostic criteria for myocarditis in dilated cardiomyopathy.
• To investigate the etiological agents and pathogenesis of myocarditis.
• To explore therapeutic implications based on myocarditis classification.

Main Methods:

• Utilized the WHO/ISFC nomenclature for cardiomyopathies.
• Established morphological diagnostic criteria for myocarditis in 1984 (Dallas criteria).
• Employed hybridization probes for direct detection of viral causes, moving beyond serological tests.

Main Results:

• Myocarditis identified in 28% of approximately 2,000 patients with presumed dilated cardiomyopathy.
• Dallas criteria provided a framework for categorizing myocarditis (acute, resolving, resolved).
• Coxsackie B viruses confirmed as a primary cause of myocarditis through advanced molecular techniques.

Conclusions:

• Myocarditis is a crucial, identifiable component in the pathogenesis of dilated cardiomyopathy.
• Standardized diagnostic criteria and etiological identification are vital for therapeutic strategies.
• Ongoing research into immunological consequences aims for rationalized treatment approaches for myocarditis-related cardiomyopathy.